Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 15/03/20061 min de leitura
Guidance for Industry on Nonclinical Safety Evaluation of Drug or Biologic Combinations; Availability
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled "Nonclinical Safety Evaluation of Drug or Biologic Combinations." This guidance provides recommendations on nonclinical approaches to support the clinical study and approval of fixed-dose combination products (FDCs), co-packaged products, and some adjunctive therapies.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →